You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.

Continue

Go back

Patient Information Leaflet & Summary of Product Characteristics (UK)

This link will take you to the electronic Medicines Compendium website which is a non-GSK website.

Summary of Product Characteristics and Patient Information Leaflet (UK)

Information for Patients Prescribed Nucala for Severe Eosinophilic Asthma

This page can help you understand more about your condition and your medication, but if you have any questions or concerns please consult your doctor, pharmacist or nurse.

I am a severe eosinophilic asthma patient who has been prescribed Nucala

Information for Patients Prescribed Nucala for uncontrolled COPD of an eosinophilic phenotype

Coming soon

Nucala is a registered trademark of the GSK group of companies

Reporting of side effects:
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet.
You can also report side effects directly via the Yellow Card Scheme at https://yellowcard.mhra.gov.uk/. By reporting side effects, you can help provide more information on the safety of this medicine.
Adverse events should also be reported to GSK on 0800 221 441.